Involvement of the benzodiazepine system in the anxiolytic-like effect of Yokukansan (Yi-gan san)

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 8, 2009, Pages 1431-1437

  Kamei, Junzo ^a   Miyata, Shigeo ^a   Ohsawa, Masahiro ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Anxiety; Behavioral and psychological symptoms of dementia; Benzodiazepine; Kampo medicine; Yokukansan

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; CHOTOKO; FLUMAZENIL; METHANOL; UNCLASSIFIED DRUG; YI GAN SAN; YOKUKANSAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SOLUBILITY; EMOTIONALITY; MALE; MAZE TEST; MOUSE; NONHUMAN; REARING; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZODIAZEPINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; EXPLORATORY BEHAVIOR; FLUMAZENIL; HEAD MOVEMENTS; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; PHYTOTHERAPY; RECEPTORS, GABA-A;

EID: 71549167299     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.07.023     Document Type: Article

References (29)

1. Boissier J.R., and Simon P. La reaction dexploration chez la souris. Therapies 17 (1962) 1225-1232
2. Boissier J.R., and Simon P. Dissociation de deux composantes dans le compartment dinvestigation de la souris. Arch Int Pharmacodyn 147 (1964) 372-378
3. Egashira N., Iwasaki K., Ishibashi A., Hayakawa K., Okuno R., Abe M., et al. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1516-1520
4. Finkel S.I. Behavioral and psychologic symptoms of dementia. Clin Geriatr Med 19 (2003) 799-824
5. Garcia-Alloza M., Tsang S.W., Gil-Bea F.J., Francis P.T., Lai M.K., Marcos B., et al. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. Neurobiol Aging 27 (2006) 1110-1117
6. 9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur J Pharmacol 365 (1999) 133-142
7. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 327 (1984) 1-5
8. Herrmann N. Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci 28 (2001) S96-S107
9. Ikeda T., Mishima K., Aoo N., Harada K., Liu A.X., Egashira N., et al. Rehabilitative training tasks improve spatial learning impairment in the water maze following hypoxic-ischemic insult in neonatal rats. Pediatr Res 59 (2006) 61-65
10. Iwasaki K., Maruyama M., Tomita N., Furukawa K., Nemoto M., Fujiwara H., et al. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry 66 (2005) 1612-1613
11. Iwasaki K., Satoh-Nakagawa T., Maruyama M., Monma Y., Nemoto M., Tomita N., et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66 (2005) 248-252
12. Kamei J., Ohsawa M., Tsuji M., Takeda H., and Matsumiya T. Modification of the effects of benzodiazepines on the exploratory behaviors of mice on a hole-board by diabetes. Jpn J Pharmacol 86 (2001) 47-54
13. Kamei J., Matsunawa Y., Miyata S., Tanaka S., and Saitoh A. Effects of nociceptin on the exploratory behavior of mice in the hole-board test. Eur J Pharmacol 489 (2004) 77-87
14. Liao J.F., Jan Y.M., Huang S.Y., Wang H.H., Yu L.L., and Chen C.F. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proc Natl Sci Counc Repub China B 19 (1995) 151-158
15. Medina J.H., Pena C., Piva M., Paladini A.C., and De Robertis E. Presence of benzodiazepine-like molecules in mammalian brain and milk. Biochem Biophys Res Commun 152 (1988) 534-539
16. Mimaki Y., Toshimizu N., Yamada K., and Sashida Y. Anti-convulsion effects of choto-san and chotoko (Uncariae Uncis cam Ramlus) in mice, and identification of the active principles. Yakugaku Zasshi 117 (1997) 1011-1021
17. Miyaoka T., Furuya M., Yasuda H., Hayashia M., Inagaki T., and Horiguchi J. Yi-gan san for the treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 150-154
18. Miyaoka T., Furuya M., Yasuda H., Hayashida M., Nishida A., Inagaki T., et al. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 761-764
19. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
20. Rodriguez-Echandia E.L., Broitman S.T., and Foscolo M.R. Effect of the chronic ingestion of chlorimipramine and desipramine on the hole board response to acute stresses in male rats. Pharmacol Biochem Behav 26 (1987) 207-210
21. Rubin E.H., Drevets W.C., and Burke W.J. The nature of psychotic symptoms in senile dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1 (1988) 16-20
22. Sangameswaran L., and De Blas A. Demonstration of benzodiazepine-like molecules in the mammalian brain with a monoclonal antibody to benzodiazepines. Proc Natl Acad Sci U S A 82 (1985) 5560-5564
23. Shinno H., Utani E., Okazaki S., Kawamukai T., Yasuda H., Inagaki T., et al. Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementiawith Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1543-1555
24. Shinno H., Inami Y., Inagaki T., Nakamura Y., and Horiguchi J. Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 881-885
25. Shinno H., Kamei M., Nakamura Y., Inami Y., and Horiguchi J. Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1749-1751
26. Takeda H., Tsuji M., and Matsumiya T. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur J Pharmacol 350 (1998) 21-29
27. Tateno M., Ukai W., Ono T., Saito S., Hashimoto E., and Saito T. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1704-1707
28. Unseld E., Krishna O.R., Fischer C., and Klotz U. Detection of desmethyldiazepam and diazepam in brain of different species and plants. Biochem Pharmacol 38 (1989) 2473-2478
29. Walsh J.S., Welch H.G., and Larson E.B. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 113 (1990) 429-434